Center for Surveillance, Immunization and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Center for Research Planning and Coordination, National Institute of Infectious Diseases, Tokyo, Japan.
Western Pac Surveill Response J. 2022 Sep 16;13(3):1-10. doi: 10.5365/wpsar.2022.13.3.943. eCollection 2022 Jul-Sep.
Monitoring the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is important due to concerns regarding infectivity, transmissibility, immune evasion and disease severity. We evaluated the temporal and regional replacement of previous SARS-CoV-2 variants by the emergent strains, Alpha and Delta.
We obtained the results of polymerase chain reaction screening tests for variants conducted in multiple commercial laboratories. Assuming that all previous strains would be replaced by one variant, the new variant detection rate was estimated by fitting a logistic growth model. We estimated the transmission advantage of each new variant over the pre-existing virus strains.
The variant with the N501Y mutation was first identified in the Kinki region in early February 2021, and by early May, it had replaced more than 90% of the previous strains. The variant with the L452R mutation was first detected in the Kanto-Koshin region in mid-May, and by early August, it comprised more than 90% of the circulating strains. Compared with pre-existing strains, the variant with the N501Y mutation showed transmission advantages of 48.2% and 40.3% in the Kanto-Koshin and Kinki regions, respectively, while the variant with the L452R mutation showed transmission advantages of 60.1% and 71.9%, respectively.
In Japan, Alpha and Delta variants displayed regional differences in the replacement timing and their relative transmission advantages. Our method is efficient in monitoring and estimating changes in the proportion of variant strains in a timely manner in each region.
由于对传染性、传播力、免疫逃逸和疾病严重程度的担忧,监测严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株的流行情况非常重要。我们评估了 Alpha 和 Delta 等新兴毒株对先前 SARS-CoV-2 变异株的时间和区域替代情况。
我们获取了多家商业实验室进行的变异体聚合酶链反应筛查检测结果。假设所有先前的毒株都将被一种变异株所取代,通过拟合逻辑增长模型来估计新变异株的检出率。我们估计了每种新变异株相对于现有病毒株的传播优势。
带有 N501Y 突变的变异株于 2021 年 2 月初在近畿地区首次被发现,到 5 月初,它已取代了超过 90%的先前毒株。带有 L452R 突变的变异株于 5 月中旬在关东-甲信地区首次被发现,到 8 月初,它已占循环株的 90%以上。与先前的毒株相比,带有 N501Y 突变的变异株在关东-甲信和近畿地区的传播优势分别为 48.2%和 40.3%,而带有 L452R 突变的变异株的传播优势分别为 60.1%和 71.9%。
在日本,Alpha 和 Delta 变异株在替代时间和相对传播优势方面存在区域差异。我们的方法能够有效地监测和及时估计每个地区变异株比例的变化。